No description extracted.
ZurichMedtech
Published on thinner evidence: weigh the verdict and its sources before you rely on it.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Growth closes $25M Growth round Published on thinner evidence, 1 source | $25M | 2026-09-21 | Swisscanto | 1 outlet. #80 in Trending |
[ VERIFIED · CORRECTED ]0.61 Published on thinner evidence: weigh the verdict and its sources before you rely on it. read against 1 source
[ BUILT WITH ]·[ SEARCH ]found by Firecrawl search: "growth round" raises million led by·[ SCRAPE ]1 page read: gsmedtech.com·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]correctedread back across 1 source·[ BRANDING ]homepage not matched·[ AGENT ]dossier built by the Firecrawl agent | ||||
Piomic Medical builds portable, non-invasive COMS devices that combine optical and magnetic stimulation to help hospitals, clinics and home-care users treat hard-to-heal wounds.
| Round | Amount | Announced | Lead |
|---|---|---|---|
| Series A | CHF 7.5M | 2022-07-29 | Swiss Diabetes Venture Fund (SDVF) |
Piomic targets hard-to-heal wounds, which its pages describe as a major healthcare burden, with a portable COMS therapy that combines optical and magnetic stimulation for hospital, outpatient and home-care use. After reporting more than 5,000 treatments and 450 patients in its initial soft launch, the company raised a USD 25 million growth financing to complete the MAVERICKS and NAZARÉ clinical programs, pursue U.S. approval and expand the platform.
Checked against 12 sources today
No homepage passed the identity check, so nothing was written. Refresh profile tries again with what the record now knows.
Diabetes Venture Fund
N&V Capital
Verve Ventures